The EU notified body code of conduct: a key tool to avoid stricter regulation or too complex to enforce?
This article was originally published in SRA
Now that an initial version of a code of conduct for notified bodies in the EU has been agreed, will it be enough to convince the European Commission that these testing and certification organisations are on their own able to raise standards across the sector to a sufficiently high level? In other words, will the code be enough to stop the commission and EU lawmakers from introducing tighter notified body-related legislation?
You may also be interested in...
What will the fall-out of political tensions between the EU and Switzerland mean for notified bodies based in Switzerland, and for the future recognition of CE marks granted in one of the most important medtech markets in Europe?
Eighteen years of free trade threatens to come to a sudden stop, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.